OpenAI Rosalind Academic Plan: Free GPT-Rosalind Access for Academic Labs

OpenAI has introduced the Rosalind Academic Plan, which gives eligible academic labs up to 30 Business Standard seats at no cost for up to 12 months, including access to GPT-Rosalind — OpenAI's dedicated life sciences model — subject to trusted-access approval. The plan matters because it lowers the cost barrier for university scientists to use frontier reasoning models and the Rosalind Workbench tool-orchestration layer for medicinal chemistry, genomics, and wet-lab work, while keeping research data out of model training by default.

What the Rosalind Academic Plan includes

Eligible labs receive three things under the plan:

Up to 30 Business Standard seats at $0 per user per month for up to 12 months.
Access to all commercially available frontier OpenAI models, subject to plan usage limits.
Access to GPT-Rosalind following trusted-access approval.

Research data shared through the Rosalind Academic Plan is not used to train OpenAI's models by default. API access is not included at this time.

Once approved, PIs and lab leads can activate free access for up to 30 named members, alongside the other OpenAI frontier models included in the plan. Verified PIs and lab leads manage member permissions and are responsible for their lab's approved use.

Who is eligible and how labs apply

The Rosalind Academic Plan is currently available to academic labs at U.S. universities. The application path depends on whether the university already has an OpenAI Enterprise agreement:

PIs and lab leads at universities without an OpenAI Enterprise agreement can apply on behalf of their labs through OpenAI's trusted access process.
Labs at universities with an existing agreement must apply through their university's Enterprise access process.

The published application flow has four steps: explore the plan, sign in and apply, complete verification, and start research after access is active. OpenAI directs applicants to its help center guide for eligibility, application requirements, and getting started.

What GPT-Rosalind is

GPT-Rosalind is described by OpenAI as a specialized life sciences model designed to support deeper reasoning on complex biological questions. It combines frontier reasoning with Rosalind Workbench, which enables specialized tool orchestration across medicinal chemistry, genomics, wet-lab assistance, and other scientific applications.

Through trusted access, approved researchers can use GPT-Rosalind to investigate sensitive scientific questions within safeguards designed for legitimate research. The announcement lists drug and protein design as one research area, covering the design of candidate drugs, therapeutic proteins, peptides, and enzymes, and the optimization of their molecular interactions, selectivity, stability, and suitability for development. The source presents this as one of seven research-area cards but does not enumerate the remaining six in the available text.

OpenAI states that distinguished academic labs are already exploring how GPT-Rosalind can support work ranging from protein design to understanding neurodegeneration.

Trusted access and safety safeguards

Access to GPT-Rosalind is gated by a verification and monitoring process rather than being granted automatically. Before activating access, OpenAI says it:

Verifies the institution's legitimacy and the PI or lab lead's identity.
Reviews the lead's professional background, institutional appointment, and authority to oversee lab access.
Assesses the lab's institutional affiliation, research activities, and intended use.
Establishes clear responsibilities for the lab lead and a designated institutional safety contact.

Safeguards continue after activation through monitoring and enforcement. For registered high-sensitivity use cases, OpenAI's safety checks account for the approved research context. When questions arise, OpenAI may follow up with researchers to clarify the work and confirm authorization. OpenAI describes this approach as designed to detect potential misuse while accounting for legitimate research context and reducing unnecessary interruptions to authorized work.

Why OpenAI frames academic labs as the starting point

OpenAI positions the plan as the first step in a broader effort to put useful AI tools in the hands of more scientists. The announcement argues that academic research lays the groundwork for later breakthroughs, citing three historical examples:

The Human Genome Project helped launch modern genomics, transforming medicine, diagnostics, and biotechnology.
Curiosity-driven work on bacterial immune systems led to CRISPR-Cas9, which revolutionized genome editing and is now advancing research in cancer, inherited disease, agriculture, and biotechnology.
Decades of university research on mRNA laid the groundwork for COVID-19 vaccines and a new generation of vaccines and therapies.

We're starting with academic labs as part of a broader effort to put useful AI tools in the hands of more scientists. By lowering the cost of access, we hope to give more researchers room to pursue ideas whose benefits could reach far beyond their own labs—from a clearer understanding of disease to better treatments and more resilient food systems.

OpenAI also ties the plan to its stated mission of ensuring that artificial general intelligence benefits all of humanity, describing the plan as an investment in scientists doing foundational work.

What the announcement does not specify

Several details are absent from the published post and should not be assumed:

No model version number, parameter count, or benchmark results for GPT-Rosalind are given.
No pricing is stated for seats beyond the academic plan's $0 per user per month for eligible labs.
No timeline is given for expanding the plan beyond U.S. universities or for adding API access.
The remaining research-area cards beyond drug and protein design are not described in the available text.

Key takeaways

The Rosalind Academic Plan offers up to 30 free Business Standard seats for up to 12 months to eligible U.S. academic labs.
GPT-Rosalind access requires trusted-access approval and is paired with Rosalind Workbench for scientific tool orchestration.
Research data shared through the plan is not used to train OpenAI's models by default.
API access is not included at this time, and labs at universities with existing OpenAI Enterprise agreements must apply through their university's Enterprise process.